--- title: "REG - Hikma Pharmaceutical - Holding(s) in Company" type: "News" locale: "en" url: "https://longbridge.com/en/news/289564831.md" description: "Hikma Pharmaceuticals announced that Wellington Management Group LLP crossed the 5% voting rights threshold on June 9, 2026. The notification details holdings through various nominee accounts and financial instruments, including equity swaps. The ultimate controlling entity is identified as Wellington Management Group LLP." datetime: "2026-06-12T08:00:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289564831.md) - [en](https://longbridge.com/en/news/289564831.md) - [zh-HK](https://longbridge.com/zh-HK/news/289564831.md) --- # REG - Hikma Pharmaceutical - Holding(s) in Company RNS Number : 0208I Hikma Pharmaceuticals Plc 12 June 2026 TR-1: Standard form for notification of major holdings LONDON, 12 June 2026 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75) announces as follows: NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Hikma Pharmaceuticals Public Limited Company 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2\. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify) iii: 3\. Details of person subject to the notification obligationiv Name Wellington Management Group LLP City and country of registered office (if applicable) Boston, United States 4\. Full name of shareholder(s) (if different from 3.) v Name VIDACOS NOMINEES LIMITED State Street Nominees Limited ROY Nominees Limited Nortrust Nominees Limited Mellon Nominees (UK) Ltd. JP Morgan Chase Nominees Limited HSBC Global Custody Nominee (UK) Limited Goldman Sachs International Euroclear Nominees Limited BBH ISL NOMINEES LTD City and country of registered office (if applicable) 5\. Date on which the threshold was crossed or reachedvi: 09/06/2026 6\. Date on which issuer notified (DD/MM/YYYY): 11/06/2026 7\. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuervii Resulting situation on the date on which threshold was crossed or reached 4.990000 0.010000 5.000000 10700713 Position of previous notification (if applicable) 8\. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii A: Voting rights attached to shares Class/type of shares ISIN code (if possible) Number of voting rightsix % of voting rights Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) GB00B0LCW083 10683885 4.990000 SUBTOTAL 8. A 10683885 4.990000% B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Type of financial instrument Expiration datex Exercise/ Conversion Periodxi Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Type of financial instrument Expiration datex Exercise/ Conversion Period xi Physical or cash settlementxii Number of voting rights % of voting rights Equity swap 15/05/2033 15/05/2033 Cash 16828 0.010000 SUBTOTAL 8.B.2 16828 0.010000% 9\. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) X Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold Wellington Management Group LLP (Chain 1) Wellington Group Holdings LLP 5.000000% Wellington Management Group LLP (Chain 1) Wellington Investment Advisors Holdings LLP 5.000000% Wellington Management Group LLP (Chain 1) Wellington Management Global Holdings, Ltd. Wellington Management Group LLP (Chain 1) Wellington Management International Ltd Wellington Management Group LLP (Chain 2) Wellington Group Holdings LLP 5.000000% Wellington Management Group LLP (Chain 2) Wellington Investment Advisors Holdings LLP 5.000000% Wellington Management Group LLP (Chain 2) Wellington Management Company LLP 10\. In case of proxy voting, please identify: Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11\. Additional informationxvi Wellington Management Company LLP is an investment management entity that manages the assets of certain funds and/or managed accounts. Wellington Management Company LLP is a direct controlled undertaking of Wellington Investment Advisors Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Group Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Management Group LLP. Wellington Management International Ltd is an investment management entity that manages the assets of certain funds and/or managed accounts. Wellington Management International Ltd is a direct controlled undertaking of Wellington Management Global Holdings, Ltd., which, in turn, is a direct controlled undertaking of Wellington Investment Advisors Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Group Holdings LLP, which, in turn, is a direct controlled undertaking of Wellington Management Group LLP. Place of completion London, UK Date of completion 11-Jun-2026 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END HOLUAUKRNOUNAAR ### Related Stocks - [HIK.UK](https://longbridge.com/en/quote/HIK.UK.md) - [STT.US](https://longbridge.com/en/quote/STT.US.md) - [NTRS.US](https://longbridge.com/en/quote/NTRS.US.md) - [JPM.US](https://longbridge.com/en/quote/JPM.US.md) - [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [SPIN.US](https://longbridge.com/en/quote/SPIN.US.md) - [NTRSO.US](https://longbridge.com/en/quote/NTRSO.US.md) - [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md) - [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md) - [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md) - [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md) - [8634.JP](https://longbridge.com/en/quote/8634.JP.md) - [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md) - [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md) - [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md) - [00005.HK](https://longbridge.com/en/quote/00005.HK.md) - [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) ## Related News & Research - [US Supreme Court backs generic drugmaker in 'skinny label' patent case](https://longbridge.com/en/news/288735377.md) - [Faron Pharmaceuticals LTD: Holding(s) in Company](https://longbridge.com/en/news/289084476.md) - [10:01 ETIn Vitro Toxicology Testing Market worth $20.97 billion by 2031 | MarketsandMarkets™](https://longbridge.com/en/news/289608726.md) - [TransThera Sciences names industry veteran Sun Delong as chief operating officer](https://longbridge.com/en/news/289608177.md) - [ZAWYA: Emirates Drug Establishment approves Etcamah®️, an innovative ESR1-targeted breast cancer treatment](https://longbridge.com/en/news/289440416.md)